Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Arch Biopartners Inc
V.ARCH
Alternate Symbol(s):
ACHFF
Technology
Scientific & Technical Instruments
Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is...
LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
TSXV:ARCH - Post Discussion
Arch Biopartners Inc
> Today’s House Positions
New Post
View:
Discussion
List
(9)
•••
Riverfolk
X
View Profile
View Bullboard History
Post by
Riverfolk
on Oct 15, 2021 8:51pm
Today’s House Positions
House Positions for C:ARCH from 20211015 to 20211015
House
Bought
$Val
Ave
Sold
$Val
Ave
Net
$Net
22 Fidelity
51,800
129,116
2.493
4,000
10,600
2.65
47,800
-118,516
83 Mackie
28,300
74,967
2.649
0
28,300
-74,967
7 TD Sec
45,263
113,332
2.504
39,803
101,715
2.555
5,460
-11,617
28 BBS
400
1,032
2.58
0
400
-1,032
84 Ind Trading
66
155
2.348
0
66
-155
19 Desjardins
50
131
2.62
0
50
-131
68 Leede
543
1,352
2.49
503
1,301
2.586
40
-51
14 ITG
0
96
239
2.49
-96
239
53 Morgan Stanley
14
35
2.50
293
703
2.399
-279
668
33 Canaccord
4,000
9,690
2.423
5,000
12,298
2.46
-1,000
2,608
13 Instinet
5,200
12,753
2.453
7,400
18,445
2.493
-2,200
5,692
80 National Bank
3,249
8,254
2.54
6,100
15,525
2.545
-2,851
7,271
9 BMO Nesbitt
3,000
7,798
2.599
6,500
17,065
2.625
-3,500
9,267
124 Questrade
365
916
2.51
4,366
10,270
2.352
-4,001
9,354
85 Scotia
3,518
9,179
2.609
8,550
21,967
2.569
-5,032
12,788
2 RBC
3,780
9,518
2.518
14,085
34,866
2.475
-10,305
25,348
79 CIBC
18,900
47,617
2.519
34,902
87,446
2.505
-16,002
39,829
1 Anonymous
60,350
149,205
2.472
97,200
242,611
2.496
-36,850
93,406
TOTAL
228,798
575,050
2.513
228,798
575,051
2.513
0
1
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Oct 15, 2021 9:56pm
Mackie has been buying a decent position the past couple days at these new highs, great to see!
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >